Vaxart's total assets for Q3 2025 were $208.99M, an increase of 27.37% from the previous quarter. VXRT total liabilities were $182.23M for the fiscal quarter, a 38.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.